our ability to secure approval by the U.S. Food and Drug Administration, or FDA, for our product candidates under Section 505(b)(2) of the Federal Food, Drug and Cosmetic Act, or FFDCA
EX-10.19 2 y80991exv10w19.htm EX-10.19 exv10w19
Exhibit 10.19
BASE SALARIES OF EXECUTIVE OFFICERS OF THE REGISTRANT
The following are the base salaries (on an annual basis) of the executive officers of the Company:
| Name and Title | Base Salary(1) | |||
Solomon S. Steiner | $ | 375,000 | ||
Chairman, President and Chief Executive Officer | ||||
Gerard J. Michel | $ | 310,000 | ||
Chief Financial Officer, Vice President Corporate Development and Treasurer | ||||
Alan Krasnser | $ | 305,000 | ||
Chief Medical Officer | ||||
Paul Bavier | $ | 205,000 | ||
General Counsel and Secretary | ||||
Erik Steiner | $ | 200,000 | ||
Vice President, Operations | ||||
Roderike Pohl | $ | 200,000 | ||
Vice President, Research | ||||
| (1) | Base salaries effective December 1, 2008. |
